Spain · AEMPS CIMA
FLUENZ TETRA SUSPENSION PARA PULVERIZACION NASAL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 113887004
- Form
- SUSPENSIÓN PARA PULVERIZACIÓN NASAL
- Composition / generic term
- vacuna anti gripal
- Source strength
- 7,0±0,5 LOG10 UFF de reagrupamientos de virus vivos atenuados para la temporada de gripe - 0,2 ml
- Authorisation holder
- Astrazeneca Ab
- Marketed in source snapshot
- No
Source-listed ingredients
- VIRUS GRIPE A H1N1 ATENUADO — 7,0±0,5 LOG10 NO DEFINIDA
- VIRUS GRIPE A H3N2 ATENUADO — 7,0±0,5 LOG10 NO DEFINIDA
- VIRUS GRIPE B (VICTORIA) ATENUADO — 7,0±0,5 LOG10 NO DEFINIDA
- VIRUS GRIPE B (YAMAGATA) ATENUADO — 7,0±0,5 LOG10 NO DEFINIDA
These values do not establish equivalence or a dose recommendation.
Packages
- FLUENZ TETRA SUSPENSION PARA PULVERIZACION NASAL, 10 envases pulverizadores (vidrio) de 0,2 ml
Source and coverage
- Professional information (original source)
- Patient leaflet (original source)
- Official document (original source)
Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Spain records →